Skip to main content
. 2019 Jan 5;56(8):5436–5455. doi: 10.1007/s12035-018-1448-3

Fig. 5. Changes in brain sphingolipid metabolism/signaling observed in Parkinson’s disease and its experimental models.

Fig. 5

Ceramide synthase (CERS) mRNAs, ceramide (Cer), and sphingomyelin (SM) species were measured in postmortem PD brains by Abbott et al. Increased CERS1 expression was found along with a shift towards shorter ceramide acyl chain lengths in brain regions most affected by the disease, although reduction in total levels of ceramide and sphingomyelin concentration was observed [192]. Reduced sphingosine kinase-1 and -2 (SPHKs) and S1P receptor 1 (S1PR1) expression was observed in the mouse MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced model [46, 193]. The MPTP model also displayed lower protein levels and activity of SPHK1 [193, 194]